nodes	percent_of_prediction	percent_of_DWPC	metapath
Primidone—CHRNA4—attention deficit hyperactivity disorder	0.762	1	CbGaD
Primidone—CHRNA4—autonomic nervous system—attention deficit hyperactivity disorder	0.00721	0.0838	CbGeAlD
Primidone—GRIA2—forebrain—attention deficit hyperactivity disorder	0.00231	0.0269	CbGeAlD
Primidone—GABRA5—forebrain—attention deficit hyperactivity disorder	0.00217	0.0252	CbGeAlD
Primidone—CHRFAM7A—forebrain—attention deficit hyperactivity disorder	0.00211	0.0245	CbGeAlD
Primidone—GRIK2—forebrain—attention deficit hyperactivity disorder	0.00209	0.0243	CbGeAlD
Primidone—GABRA4—forebrain—attention deficit hyperactivity disorder	0.00197	0.0229	CbGeAlD
Primidone—Methylphenobarbital—CHRNA4—attention deficit hyperactivity disorder	0.00192	0.598	CrCbGaD
Primidone—CHRNA7—forebrain—attention deficit hyperactivity disorder	0.0017	0.0198	CbGeAlD
Primidone—CHRNA4—forebrain—attention deficit hyperactivity disorder	0.00168	0.0195	CbGeAlD
Primidone—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00165	0.0191	CbGeAlD
Primidone—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00165	0.0191	CbGeAlD
Primidone—GRIA2—midbrain—attention deficit hyperactivity disorder	0.00153	0.0178	CbGeAlD
Primidone—GABRA2—forebrain—attention deficit hyperactivity disorder	0.0015	0.0175	CbGeAlD
Primidone—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00145	0.0169	CbGeAlD
Primidone—CHRNA7—cardiovascular system—attention deficit hyperactivity disorder	0.00144	0.0167	CbGeAlD
Primidone—CHRNA4—cardiovascular system—attention deficit hyperactivity disorder	0.00142	0.0165	CbGeAlD
Primidone—GRIK2—midbrain—attention deficit hyperactivity disorder	0.00138	0.016	CbGeAlD
Primidone—Phenobarbital—CHRNA4—attention deficit hyperactivity disorder	0.00129	0.402	CrCbGaD
Primidone—GRIA2—nervous system—attention deficit hyperactivity disorder	0.00126	0.0146	CbGeAlD
Primidone—GABRA6—nervous system—attention deficit hyperactivity disorder	0.00121	0.0141	CbGeAlD
Primidone—GRIA2—central nervous system—attention deficit hyperactivity disorder	0.00121	0.0141	CbGeAlD
Primidone—GRIA2—cerebellum—attention deficit hyperactivity disorder	0.00118	0.0137	CbGeAlD
Primidone—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00118	0.0137	CbGeAlD
Primidone—GABRA6—central nervous system—attention deficit hyperactivity disorder	0.00117	0.0136	CbGeAlD
Primidone—CHRFAM7A—nervous system—attention deficit hyperactivity disorder	0.00114	0.0133	CbGeAlD
Primidone—GABRA6—cerebellum—attention deficit hyperactivity disorder	0.00114	0.0133	CbGeAlD
Primidone—GRIK2—nervous system—attention deficit hyperactivity disorder	0.00113	0.0132	CbGeAlD
Primidone—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.00113	0.0132	CbGeAlD
Primidone—CHRNA4—midbrain—attention deficit hyperactivity disorder	0.00111	0.0129	CbGeAlD
Primidone—CHRFAM7A—central nervous system—attention deficit hyperactivity disorder	0.0011	0.0128	CbGeAlD
Primidone—GABRA3—nervous system—attention deficit hyperactivity disorder	0.0011	0.0127	CbGeAlD
Primidone—GRIK2—central nervous system—attention deficit hyperactivity disorder	0.00109	0.0127	CbGeAlD
Primidone—GABRG2—midbrain—attention deficit hyperactivity disorder	0.00109	0.0126	CbGeAlD
Primidone—GABRB2—midbrain—attention deficit hyperactivity disorder	0.00109	0.0126	CbGeAlD
Primidone—GABRA4—nervous system—attention deficit hyperactivity disorder	0.00107	0.0124	CbGeAlD
Primidone—GRIK2—cerebellum—attention deficit hyperactivity disorder	0.00107	0.0124	CbGeAlD
Primidone—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.00105	0.0123	CbGeAlD
Primidone—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.00103	0.0119	CbGeAlD
Primidone—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.001	0.0117	CbGeAlD
Primidone—GRIA2—brain—attention deficit hyperactivity disorder	0.00096	0.0112	CbGeAlD
Primidone—GABRA1—midbrain—attention deficit hyperactivity disorder	0.000959	0.0111	CbGeAlD
Primidone—GABRA6—brain—attention deficit hyperactivity disorder	0.000927	0.0108	CbGeAlD
Primidone—CHRNA7—nervous system—attention deficit hyperactivity disorder	0.000924	0.0107	CbGeAlD
Primidone—CHRNA4—nervous system—attention deficit hyperactivity disorder	0.000912	0.0106	CbGeAlD
Primidone—GABRA5—brain—attention deficit hyperactivity disorder	0.0009	0.0105	CbGeAlD
Primidone—GABRB2—nervous system—attention deficit hyperactivity disorder	0.000893	0.0104	CbGeAlD
Primidone—GABRG2—nervous system—attention deficit hyperactivity disorder	0.000893	0.0104	CbGeAlD
Primidone—CHRNA7—central nervous system—attention deficit hyperactivity disorder	0.00089	0.0103	CbGeAlD
Primidone—CHRNA4—central nervous system—attention deficit hyperactivity disorder	0.000878	0.0102	CbGeAlD
Primidone—CHRFAM7A—brain—attention deficit hyperactivity disorder	0.000875	0.0102	CbGeAlD
Primidone—GRIK2—brain—attention deficit hyperactivity disorder	0.000867	0.0101	CbGeAlD
Primidone—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.00086	0.00999	CbGeAlD
Primidone—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.00086	0.00999	CbGeAlD
Primidone—CHRNA4—cerebellum—attention deficit hyperactivity disorder	0.000858	0.00997	CbGeAlD
Primidone—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.00084	0.00977	CbGeAlD
Primidone—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.00084	0.00977	CbGeAlD
Primidone—GABRA3—brain—attention deficit hyperactivity disorder	0.000837	0.00973	CbGeAlD
Primidone—GABRA4—brain—attention deficit hyperactivity disorder	0.000816	0.00948	CbGeAlD
Primidone—GABRA2—nervous system—attention deficit hyperactivity disorder	0.000816	0.00948	CbGeAlD
Primidone—GABRA1—nervous system—attention deficit hyperactivity disorder	0.000789	0.00917	CbGeAlD
Primidone—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.000786	0.00913	CbGeAlD
Primidone—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.000768	0.00892	CbGeAlD
Primidone—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.000759	0.00882	CbGeAlD
Primidone—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.000742	0.00863	CbGeAlD
Primidone—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000724	0.00842	CbGeAlD
Primidone—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000717	0.00834	CbGeAlD
Primidone—CHRNA7—brain—attention deficit hyperactivity disorder	0.000706	0.00821	CbGeAlD
Primidone—CHRNA4—brain—attention deficit hyperactivity disorder	0.000697	0.0081	CbGeAlD
Primidone—GABRB2—brain—attention deficit hyperactivity disorder	0.000683	0.00793	CbGeAlD
Primidone—GABRG2—brain—attention deficit hyperactivity disorder	0.000683	0.00793	CbGeAlD
Primidone—GABRA2—brain—attention deficit hyperactivity disorder	0.000624	0.00725	CbGeAlD
Primidone—GABRA1—brain—attention deficit hyperactivity disorder	0.000603	0.00701	CbGeAlD
Primidone—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000465	0.0054	CbGeAlD
Primidone—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000448	0.0052	CbGeAlD
Primidone—CYP2C8—brain—attention deficit hyperactivity disorder	0.000396	0.00461	CbGeAlD
Primidone—CYP2B6—brain—attention deficit hyperactivity disorder	0.000355	0.00413	CbGeAlD
Primidone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000351	0.00408	CbGeAlD
Primidone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000338	0.00393	CbGeAlD
Primidone—GABRB2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000237	0.0016	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000235	0.00158	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000231	0.00156	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000231	0.00155	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00023	0.00155	CbGpPWpGaD
Primidone—CHRNA7—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000228	0.00153	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000226	0.00152	CbGpPWpGaD
Primidone—CHRNA7—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000226	0.00152	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000226	0.00152	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000226	0.00152	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000225	0.00152	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000225	0.00151	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000225	0.00151	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000223	0.0015	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000222	0.0015	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000222	0.00149	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000219	0.00147	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000218	0.00147	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000217	0.00146	CbGpPWpGaD
Primidone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000217	0.00146	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000217	0.00146	CbGpPWpGaD
Primidone—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000214	0.00144	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000211	0.00142	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00021	0.00141	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000209	0.00141	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000208	0.0014	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000207	0.0014	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000205	0.00138	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000204	0.00137	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000201	0.00136	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0002	0.00135	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000199	0.00134	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000199	0.00134	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000198	0.00133	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000195	0.00131	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000194	0.00131	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000194	0.0013	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000192	0.00129	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000191	0.00129	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000191	0.00129	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000191	0.00129	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000191	0.00129	CbGpPWpGaD
Primidone—GRIK2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00019	0.00128	CbGpPWpGaD
Primidone—GRIA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00019	0.00128	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00019	0.00128	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00019	0.00128	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000188	0.00126	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000188	0.00126	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000187	0.00126	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000187	0.00126	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000186	0.00125	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000185	0.00125	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000185	0.00125	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000185	0.00125	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000185	0.00124	CbGpPWpGaD
Primidone—CHRNA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000184	0.00124	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000184	0.00124	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000183	0.00123	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000183	0.00123	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000182	0.00123	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000182	0.00122	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000181	0.00122	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000179	0.00121	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000178	0.0012	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000177	0.00119	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000175	0.00118	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000174	0.00117	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000173	0.00117	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000173	0.00117	CbGpPWpGaD
Primidone—CHRNA7—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000173	0.00117	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000173	0.00117	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000172	0.00116	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000171	0.00115	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00017	0.00115	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000169	0.00114	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000167	0.00113	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000166	0.00112	CbGpPWpGaD
Primidone—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000165	0.00111	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000164	0.00111	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000163	0.0011	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000161	0.00109	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000161	0.00108	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00016	0.00108	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000159	0.00107	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000159	0.00107	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000159	0.00107	CbGpPWpGaD
Primidone—GABRA6—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000158	0.00106	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000157	0.00106	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000156	0.00105	CbGpPWpGaD
Primidone—GABRA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000156	0.00105	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000155	0.00104	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000153	0.00103	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000152	0.00102	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000152	0.00102	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000149	0.001	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000147	0.000987	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000147	0.000987	CbGpPWpGaD
Primidone—GRIA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000146	0.00098	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000145	0.000978	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000145	0.000978	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000144	0.000968	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000143	0.000966	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000143	0.000963	CbGpPWpGaD
Primidone—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000143	0.000961	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000142	0.000957	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000142	0.000953	CbGpPWpGaD
Primidone—CHRNA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000141	0.000951	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000141	0.000951	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00014	0.00094	CbGpPWpGaD
Primidone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00014	0.000939	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000139	0.000937	CbGpPWpGaD
Primidone—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000139	0.000934	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000139	0.000933	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000137	0.000923	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000136	0.000917	CbGpPWpGaD
Primidone—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000136	0.000917	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000135	0.00091	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000135	0.000907	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000134	0.000904	CbGpPWpGaD
Primidone—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000134	0.000901	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000133	0.000895	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000131	0.000885	CbGpPWpGaD
Primidone—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000131	0.000879	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00013	0.000872	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000126	0.000847	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000125	0.000841	CbGpPWpGaD
Primidone—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000125	0.000838	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000124	0.000832	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000122	0.000821	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000121	0.000818	CbGpPWpGaD
Primidone—GABRA6—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000121	0.000815	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00012	0.000811	CbGpPWpGaD
Primidone—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00012	0.000805	CbGpPWpGaD
Primidone—CHRNA7—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000119	0.000802	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000118	0.000798	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000116	0.000782	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000115	0.000774	CbGpPWpGaD
Primidone—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000114	0.000768	CbGpPWpGaD
Primidone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000114	0.000765	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000113	0.000764	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00011	0.000742	CbGpPWpGaD
Primidone—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000109	0.000736	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000107	0.00072	CbGpPWpGaD
Primidone—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000106	0.000715	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000105	0.000707	CbGpPWpGaD
Primidone—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000104	0.000702	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000104	0.000697	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000103	0.000695	CbGpPWpGaD
Primidone—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000103	0.00069	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000101	0.000678	CbGpPWpGaD
Primidone—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.0001	0.000673	CbGpPWpGaD
Primidone—CHRNA4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	9.71e-05	0.000654	CbGpPWpGaD
Primidone—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	9.7e-05	0.000653	CbGpPWpGaD
Primidone—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	8.87e-05	0.000597	CbGpPWpGaD
Primidone—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	8.82e-05	0.000594	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	8.81e-05	0.000593	CbGpPWpGaD
Primidone—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	8.76e-05	0.000589	CbGpPWpGaD
Primidone—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.74e-05	0.000589	CbGpPWpGaD
Primidone—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	8.7e-05	0.000585	CbGpPWpGaD
Primidone—GABRA6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.71e-05	0.000519	CbGpPWpGaD
Primidone—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.62e-05	0.000513	CbGpPWpGaD
Primidone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	7.49e-05	0.000504	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.46e-05	0.000503	CbGpPWpGaD
Primidone—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.41e-05	0.000499	CbGpPWpGaD
Primidone—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.36e-05	0.000496	CbGpPWpGaD
Primidone—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.96e-05	0.000469	CbGpPWpGaD
Primidone—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.77e-05	0.000456	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.66e-05	0.000449	CbGpPWpGaD
Primidone—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.64e-05	0.000447	CbGpPWpGaD
Primidone—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.62e-05	0.000445	CbGpPWpGaD
Primidone—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.57e-05	0.000442	CbGpPWpGaD
Primidone—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.53e-05	0.00044	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	6.39e-05	0.00043	CbGpPWpGaD
Primidone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	6.39e-05	0.00043	CbGpPWpGaD
Primidone—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.37e-05	0.000429	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.08e-05	0.000409	CbGpPWpGaD
Primidone—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.03e-05	0.000406	CbGpPWpGaD
Primidone—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	6.01e-05	0.000405	CbGpPWpGaD
Primidone—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.99e-05	0.000403	CbGpPWpGaD
Primidone—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.57e-05	0.000375	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.19e-05	0.00035	CbGpPWpGaD
Primidone—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.16e-05	0.000347	CbGpPWpGaD
Primidone—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.12e-05	0.000345	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.01e-05	0.00027	CbGpPWpGaD
Primidone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.98e-05	0.000268	CbGpPWpGaD
Primidone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.95e-05	0.000266	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.61e-05	0.000243	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.05e-05	0.000206	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.72e-05	0.000183	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.49e-05	0.000168	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.49e-05	0.000168	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.48e-05	0.000167	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.45e-05	0.000165	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.28e-05	0.000153	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.12e-05	0.000143	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.11e-05	0.000142	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	2.11e-05	0.000142	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	2.07e-05	0.00014	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.99e-05	0.000134	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.93e-05	0.00013	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.89e-05	0.000128	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	1.88e-05	0.000127	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.88e-05	0.000127	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.85e-05	0.000125	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.72e-05	0.000116	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	1.71e-05	0.000115	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.71e-05	0.000115	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.69e-05	0.000114	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.68e-05	0.000113	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.64e-05	0.00011	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.6e-05	0.000108	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.57e-05	0.000106	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	1.51e-05	0.000102	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.5e-05	0.000101	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.5e-05	0.000101	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.47e-05	9.87e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.47e-05	9.87e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.44e-05	9.71e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.43e-05	9.64e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.37e-05	9.23e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.34e-05	9.02e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.31e-05	8.79e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	1.28e-05	8.59e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	1.27e-05	8.53e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.23e-05	8.28e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.17e-05	7.89e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	1.14e-05	7.67e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	1.13e-05	7.62e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.13e-05	7.61e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.13e-05	7.61e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	7.51e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.11e-05	7.49e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.1e-05	7.39e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.04e-05	6.99e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.03e-05	6.96e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.03e-05	6.95e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1e-05	6.74e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.04e-06	6.09e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	8.88e-06	5.98e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	8.82e-06	5.93e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.61e-06	5.79e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.55e-06	5.76e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.85e-06	4.61e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.8e-06	4.58e-05	CbGpPWpGaD
Primidone—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	6.47e-06	4.35e-05	CbGpPWpGaD
Primidone—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	5.47e-06	3.69e-05	CbGpPWpGaD
Primidone—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	4.89e-06	3.29e-05	CbGpPWpGaD
Primidone—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	4.46e-06	3e-05	CbGpPWpGaD
Primidone—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.81e-06	2.56e-05	CbGpPWpGaD
Primidone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.94e-06	1.98e-05	CbGpPWpGaD
